Table 8 Results of a 26-week Trial of Liraglutide Injection as Add-on to Metformin and Sulfonylurea in Adult Patients with Type 2 Diabetes Mellitus a Liraglutide Injection Compared to Exenatide, Both as Add-on to Metformin and/or Sulfonylurea Therapy In this 26-week, open-label trial, 464 adult patients with type 2 diabetes mellitus on a background of metformin monotherapy, sulfonylurea monotherapy or a combination of metformin and sulfonylurea were randomized to once daily liraglutide injection 1.8 mg or exenatide 10 mcg twice daily
I would not currently recommend TB-500 given the concerning data regarding thymosin beta-4's association with tumor progression in multiple cancer types
declare a US patent No US10888577B2: PCT international patent WO2017143430A1, entitled MiRNA biomarkers for cartilage degeneration
Some effects may extend longer, requiring medical supervision
900 Blake Wilbur Dr Fl 2 Palo Alto, CA 94304 Phone: 650-736-5800 Our Doctors For Patients A referral from your primary care doctor is required
MORE VIDEOS IN Obesity What is a GLP-1